Leading partner in TIDES

Peptide & Oligonucleotide CDMO

Bachem is a leading, innovation-driven company that develops and manufactures peptides and oligonucleotides as Active Pharmaceutical Ingredients (APIs), from early clinical development through to commercial GMP supply, for pharma and biotech worldwide.

50+

Years of experience

150+

Ongoing CMC projects

2,500+

Team members globally

Our peptide and oligonucleotide CDMO services

End-to-end CDMO support for peptide and oligonucleotide therapeutics. From research synthesis to commercial manufacturing, with integrated analytical, regulatory, and catalog services at every phase.

  • Clinical development for Peptides

    Comprehensive support for the clinical development of your Peptide API.

    Arrow
  • Commercial manufacturing of Peptides

    GMP manufacturing of Peptide APIs.

    Arrow
  • Custom Peptide synthesis

    Custom peptides synthesized for your research needs.

    Arrow
  • Catalog products

    Your research made easy with thousands of catalog products.

    Arrow
  • Clinical development for Oligonucleotides

    Comprehensive support for the clinical development of your Oligonucleotide API.

    Arrow
  • Commercial manufacturing of Oligonucleotides

    GMP manufacturing of Oligonucleotide APIs.

    Arrow

Why partner with Bachem?

  • End-to-end vertical integration. From amino acid derivatives and building blocks through to large-scale commercial API, supported by deep analytical, quality and regulatory expertise. 
  • Global manufacturing you can rely on. Four GMP-certified sites across Switzerland and the United States, delivering reliable global supply at scales from milligrams to multi-tonne commercial volumes.
  • Science-led. Sustainability-committed. Innovative by nature, responsible by design, and focused on getting your therapeutics to patients safely and at scale.

Become part of the Bachem world

Our success is driven by our people. We offer an international, science-driven environment where expertise, collaboration and continuous development matter. From apprentices to experienced professionals, we create opportunities to grow, take ownership and make a real impact in a dynamic and expanding industry.

Upcoming Events

Manufacturing for more than 50 years

Image

FAQs

Bachem is a Contract Development and Manufacturing Organisation (CDMO) that develops and manufactures peptides and oligonucleotides as Active Pharmaceutical Ingredients (APIs). Founded in 1971, Bachem supports pharmaceutical and biotechnology companies across the full product lifecycle — from early clinical development through to commercial-scale GMP supply.

Yes. Bachem manufactures oligonucleotide APIs under GMP conditions and supports them from clinical development through commercial supply. Bachem began its strategic expansion into oligonucleotide development and manufacturing from 2018 onward to meet growing global demand for these therapeutics, and its oligonucleotide platforms include single-strand oligos, duplex APIs such as siRNA, antisense oligonucleotides, and a range of conjugates including GalNAc.

Yes. Bachem manufactures APIs under Good Manufacturing Practice (GMP) at its certified sites, supported by decades of global regulatory and production experience. Its quality and regulatory expertise covers requirements for clinical and commercial drug substance supply.

Bachem offers clinical development for peptide new chemical entities (NCEs), commercial GMP manufacturing of peptide APIs, custom peptide synthesis for research, amino acid derivatives and building blocks, cosmetic peptides, peptides for diagnostics and medical devices, and a catalog of thousands of research products. These are supported by project management, quality and regulatory, analytical, as well as supply and vertical integration services.

You can reach Bachem through our contact form to discuss your peptide or oligonucleotide development and manufacturing requirements. 

box-pattern